Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per Share (CNTB)

Q: What does CUSIP G23549101 represent in this 13F holders report?

CUSIP G23549101 is the security identifier for CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per Share used to aggregate holder disclosures.

Q: How many institutions held CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per Share in Q3 2026?

7 institutional investors reported CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per Share for Q3 2026. Use the holders table for investor-level position and value details.

CUSIP: G23549101

Q3 2026 13F Holders as of 30 Sep 2026

Security type / class: Equity / Ordinary Shares, par value $0.000174 per Share
Total 13F shares: 68,078
Total 13F value: $74,386
Share change: -14,644
SEC-reported price per share: $1.10
Number of holders: 7
Value change: -$35,397
Number of buys: 3
Number of sells: 1
Shares outstanding: 62,989,660

Security key

G23549101

Report period

Q3 2026

Institutions

Top holders

CNTB full security history Ownership snapshot Full 13F holder table Previous quarter: Q3 2025 Connect Biopharma Holdings Ltd SEC filings Connect Biopharma Holdings Ltd company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP G23549101

Previous quarter: Q3 2025

Recent filing periods:

Q3 2026 Q3 2025

Ownership snapshot

Top reported holders of CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per Share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Panacea Innovation Ltd

Disclosed value leader

Panacea Innovation Ltd

Comparable rows

5/15

Latest evidence

30 Sep 2026

13D/G 13F 3/4/5 Lead comparable stake: 21% 10 rows are not safely comparable across share classes. 13D/G row: Panacea Innovation Ltd Showing 1-6 of 15 holder rows.

Quick read

Panacea Innovation Ltd leads the comparable SEC ownership view at 21%.

5 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Panacea Innovation Ltd's linked filing trail.

Comparable ownership Top 5

Panacea Innovation Ltd 21%

BioFortune Inc 9.6%

Ikarian Capital, LLC 6.9%

BML Investment Partners, L.P. 6.8%

Wei Zheng 4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Panacea Innovation Ltd	13D/G Panacea Innovation Limited 13D/G	21% Reported 13D/G · 31 Mar 2026	$36,848,000 13,160,000 shares	+$3,248,000	31 Mar 2026
BioFortune Inc	13D/G Wubin Pan 13D/G	9.6% Reported 13D/G · 14 Apr 2026	$16,995,010 6,026,813 shares	$0	14 Apr 2026
Ikarian Capital, LLC	13F 13D/G Company 13F 13D/G	6.9% Reported 13D/G · 30 Jun 2026	$10,801,710 4,538,534 shares	—	30 Jun 2026
BML Investment Partners, L.P.	13D/G Braden M Leonard 13D/G	6.8% Reported 13D/G · 30 Sep 2026	$8,784,664 4,264,400 shares	$0	30 Sep 2026
Wei Zheng	13D/G 13D/G	4% Reported 13D/G · 30 Jun 2026	$5,998,454 2,520,359 shares	-$3,226,511	30 Jun 2026
James Huang	3/4/5 Director 3/4/5	— denominator unverified	$32,974,193 13,310,000 shares	+$4,373,610	29 May 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

68,078

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q3 2025 Across Filers

Q3 2025 holders

Q3 2026 holders

Holder diff

-8

Investor	Q3 2025 Shares	Q3 2026 Shares	Share Diff	Share Chg %	Q3 2025 value	Q3 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend